GenCaps is a clinical-stage pharmaceutical company developing differentiated oral reformulations for assisted patient populations
Focus
Building a portfolio around growing medical and societal needs.
We focus where a targeted change to an existing medicine can make a real difference — especially where treatment is long-term, burden rises with age, or patients depend on others to help manage their medicines.
CNS
Niche indications
Underserved populations
Building value
From concept to partner-ready
Starting from the established safety and efficacy of existing small molecules, we design formulations that address tolerability, adherence, dosing and administration, bringing value to patients and to those who help care for them.
We bring together seasoned pharmaceutical, regulatory, medical and commercial expertise to turn promising product concepts into partner-ready opportunities.
Partnering
Centrally located. Flexible by design.
From Luxembourg, we are well placed to collaborate across neighbouring markets, wider Europe and beyond — and to give each project the structure that suits it. We welcome contact from both individual innovators and companies large and small who would like to explore ideas with us.
We use only strictly necessary cookies to run this site (e.g. keeping the contact form secure). We don't use analytics or advertising cookies. See our Privacy Policy for details.